You can:
Name | Vasopressin V1b receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | AVPR1B |
Synonym | AVPR3 Vasopressin V3 receptor vasopressin V1b receptor V3/V1b pituitary vasopressin receptor V3 [ Show all ] |
Disease | Anxiety disorder Major depressive disorder; Anxiety Major depressive disorder |
Length | 424 |
Amino acid sequence | MDSGPLWDANPTPRGTLSAPNATTPWLGRDEELAKVEIGVLATVLVLATGGNLAVLLTLGQLGRKRSRMHLFVLHLALTDLAVALFQVLPQLLWDITYRFQGPDLLCRAVKYLQVLSMFASTYMLLAMTLDRYLAVCHPLRSLQQPGQSTYLLIAAPWLLAAIFSLPQVFIFSLREVIQGSGVLDCWADFGFPWGPRAYLTWTTLAIFVLPVTMLTACYSLICHEICKNLKVKTQAWRVGGGGWRTWDRPSPSTLAATTRGLPSRVSSINTISRAKIRTVKMTFVIVLAYIACWAPFFSVQMWSVWDKNAPDEDSTNVAFTISMLLGNLNSCCNPWIYMGFNSHLLPRPLRHLACCGGPQPRMRRRLSDGSLSSRHTTLLTRSSCPATLSLSLSLTLSGRPRPEESPRDLELADGEGTAETIIF |
UniProt | P47901 |
Protein Data Bank | N/A |
GPCR-HGmod model | P47901 |
3D structure model | This predicted structure model is from GPCR-EXP P47901. |
BioLiP | N/A |
Therapeutic Target Database | T59881 |
ChEMBL | CHEMBL1921 |
IUPHAR | 367 |
DrugBank | BE0000773 |
Name | CHEMBL512257 |
---|---|
Molecular formula | C20H18N6O2 |
IUPAC name | 2-[5-(methoxymethyl)-4-(6-methoxypyridin-3-yl)-1,2,4-triazol-3-yl]-5-phenylpyrazine |
Molecular weight | 374.404 |
Hydrogen bond acceptor | 7 |
Hydrogen bond donor | 0 |
XlogP | 1.2 |
Synonyms | BDBM50262208 2-(5-(methoxymethyl)-4-(6-methoxypyridin-3-yl)-4H-1,2,4-triazol-3-yl)-5-phenylpyrazine |
Inchi Key | CEKVKDRXUDAAKU-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C20H18N6O2/c1-27-13-18-24-25-20(26(18)15-8-9-19(28-2)23-10-15)17-12-21-16(11-22-17)14-6-4-3-5-7-14/h3-12H,13H2,1-2H3 |
PubChem CID | 44577938 |
ChEMBL | CHEMBL512257 |
IUPHAR | N/A |
BindingDB | 50262208 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Activity | <10.0 uM | PMID18639455 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417